Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04663269 · ClinicalTrials.gov registry record · Phase 4
Regional Erector Spinae Analgesic Block vs Standard of Care Undergoing Percutaneous Nephrolithotomy
A Phase 4 study, sponsored by Indiana University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT04663269 is a Phase 4 study that was terminated before completion, run by Indiana University. The registered enrollment target is 5 participants.
The verdict
NCT04663269, a Phase 4 study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if adding a spinal block (medicine that will numb parts of the body to block pain) along with standard pain control at the incision site will decrease the need for narcotics for pain management and decrease the percentage of patients requiring hospital admission for pain control during postoperative , in-hospital, care after a percutaneous nephrolithotomy (PCNL) (surgery to remove kidney stones), commonly called PERC.
Interventions
- DRUG 4mg PF Dexamethasone
- DRUG Control Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2020-02-24 |
| Est. Completion | 2020-09-24 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04663269
The ClinicalTrials.gov registry entry for NCT04663269 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 4mg PF Dexamethasone is the first listed.
NCT04663269 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04663269 about?
NCT04663269 is a clinical study titled "Regional Erector Spinae Analgesic Block vs Standard of Care Undergoing Percutaneous Nephrolithotomy". The purpose of this study is to determine if adding a spinal block (medicine that will numb parts of the body to block pain) along with standard pain control at the incision site will decrease the need for narcotics for pain management and decrease the percentage of patients requiring hospital admis...
What is the current status of trial NCT04663269?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2020-02-24. Estimated completion is 2020-09-24.
What interventions are being tested in trial NCT04663269?
The interventions under investigation include: 4mg PF Dexamethasone (DRUG), Control Test (DRUG).
Who is sponsoring clinical trial NCT04663269?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.